These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27906152)

  • 1. In brief: Phentermine (Lomaira) for weight loss.
    Med Lett Drugs Ther; 2016 Dec; 58(1509):158. PubMed ID: 27906152
    [No Abstract]   [Full Text] [Related]  

  • 2. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACS chemical neuroscience molecule spotlight on Qnexa.
    Mercer SL
    ACS Chem Neurosci; 2011 Apr; 2(4):183-4. PubMed ID: 22778866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FDA's assessment of two drugs for chronic weight management.
    Colman E; Golden J; Roberts M; Egan A; Weaver J; Rosebraugh C
    N Engl J Med; 2012 Oct; 367(17):1577-9. PubMed ID: 23050510
    [No Abstract]   [Full Text] [Related]  

  • 5. A review of the metabolic effects of controlled-release Phentermine/Topiramate.
    Kiortsis DN
    Hormones (Athens); 2013; 12(4):507-16. PubMed ID: 24457398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2 new drugs for weight loss.
    Med Lett Drugs Ther; 2012 Sep; 54(1398):69-71. PubMed ID: 22992487
    [No Abstract]   [Full Text] [Related]  

  • 7. Phentermine plus topiramate in the treatment of obesity.
    Malgarini RB; Pimpinella G
    Lancet; 2011 Jul; 378(9786):125-6; author reply 126-7. PubMed ID: 21742167
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity.
    Hendricks EJ; Greenway FL; Westman EC; Gupta AK
    Obesity (Silver Spring); 2011 Dec; 19(12):2351-60. PubMed ID: 21527891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two anti-obesity hopefuls and their safety.
    Bello NT; Campbell SC
    Expert Opin Drug Saf; 2012 Sep; 11(5):681-3. PubMed ID: 22788876
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison table: some FDA-approved drugs for weight management.
    Med Lett Drugs Ther; 2018 Jun; 60(1548):e98-e100. PubMed ID: 29913464
    [No Abstract]   [Full Text] [Related]  

  • 11. Phentermine: an appetite-suppressant amphetamine classified as a narcotic in France. Is a combination with topiramate on the horizon?
    Prescrire Int; 2012 Sep; 21(130):209. PubMed ID: 23016252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the Effects of Combined Liraglutide and Phentermine on Metabolic Parameters, Blood Pressure, and Heart Rate in Lean and Obese Male Mice.
    Simonds SE; Pryor JT; Koegler FH; Buch-Rasmussen AS; Kelly LE; Grove KL; Cowley MA
    Diabetes; 2019 Apr; 68(4):683-695. PubMed ID: 30674622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination phentermine and topiramate extended release in the management of obesity.
    Alfaris N; Minnick AM; Hopkins CM; Berkowitz RI; Wadden TA
    Expert Opin Pharmacother; 2015 Jun; 16(8):1263-74. PubMed ID: 25958964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic therapies for obesity.
    Kaplan LM
    Gastroenterol Clin North Am; 2010 Mar; 39(1):69-79. PubMed ID: 20202580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination phentermine/topiramate for obesity treatment in primary care: a review.
    Xiong GL; Gadde KM
    Postgrad Med; 2014 Mar; 126(2):110-6. PubMed ID: 24685974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unambiguous identification of obesity trials.
    Zarin DA; Tse T
    N Engl J Med; 2013 Feb; 368(6):580-1. PubMed ID: 23388022
    [No Abstract]   [Full Text] [Related]  

  • 17. Coadministration of lorcaserin and phentermine for weight management: A 12-week, randomized, pilot safety study.
    Smith SR; Garvey WT; Greenway FL; Zhou S; Fain R; Pilson R; Fujioka K; Aronne LJ
    Obesity (Silver Spring); 2017 May; 25(5):857-865. PubMed ID: 28440045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity Epidemic: Pharmaceutical Weight Loss.
    Curry SA
    R I Med J (2013); 2017 Mar; 100(2):18-20. PubMed ID: 28246654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia).
    Shyh G; Cheng-Lai A
    Cardiol Rev; 2014; 22(1):43-50. PubMed ID: 24304809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological approaches to intervention.
    Guy-Grand B
    Int J Obes Relat Metab Disord; 1997 Mar; 21 Suppl 1():S22-4. PubMed ID: 9130037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.